An Apoptosis-Associated Mammary Protein Deficiency Leads to Enhanced Production of IgM Antibodies against Multiple Damage-Associated Molecules

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Chikazawa, Miho ^a   Otaki, Natsuki ^a   Shibata, Takahiro ^a   Yasueda, Takehiko ^a   Matsuda, Tsukasa ^a   Uchida, Koji ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 OXO 2 NONENAL; IMMUNOGLOBULIN M ANTIBODY; LACTADHERIN; OMEGA 6 FATTY ACID; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CELL PHAGOCYTOSIS; CLEARANCE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MALE; NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN MODIFICATION; WESTERN BLOTTING;

ALDEHYDES; ANIMALS; ANNEXIN A5; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; APOPTOSIS; EPITOPES; HUMANS; IMMUNOGLOBULIN M; JURKAT CELLS; LIPID PEROXIDATION; MICE; MILK PROTEINS; OXIDATION-REDUCTION; PHAGOCYTOSIS; PROPIDIUM;

EID: 84880074160     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068468     Document Type: Article

References (56)

1. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, et al. (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-187.
2. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, et al. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150.
3. Kranich J, Krautler NJ, Heinen E, Polymenidou M, Bridel C, et al. (2008) Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med 205: 1293-1302.
4. Miyasaka K, Hanayama R, Tanaka M, Nagata S, (2004) Expression of milk fat globule epidermal growth factor 8 in immature dendritic cells for engulfment of apoptotic cells. Eur J Immunol 34: 1414-1422.
5. Brissette MJ, Lepage S, Lamonde AS, Sirois I, Groleau J, et al. (2012) MFG-E8 released by apoptotic endothelial cells triggers anti-inflammatory macrophage reprogramming. PLoS ONE 7: e36368.
6. Yamaguchi H, Takagi J, Miyamae T, Yokota S, Fujimoto T, et al. (2008) Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus. J Leukoc Biol 83: 1300-1307.
7. Herlands RA, Christensen SR, Sweet RA, Hershberg U, Shlomchik MJ, (2008) T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 29: 249-260.
8. Peng YF, Elkon KB, (2011) Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J Clin Invest 121: 2221-2241.
9. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, et al. (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46: 191-201.
10. Iuliano L, Pratico D, Ferro D, Pittoni V, Valesini G, et al. (1997) Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood 90: 3931-3935.
11. Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, et al. (1997) Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 23: 357-360.
12. Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, et al. (2005) Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 52: 192-200.
13. Toyoda K, Nagae R, Akagawa M, Ishino K, Shibata T, et al. (2007) Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of anti-DNA response. J Biol Chem 282: 25769-25778.
14. Otaki N, Chikazawa M, Nagae R, Shimozu Y, Shibata T, et al. (2010) Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies. J Biol Chem 285: 33834-33842.
15. Brash AR, Song W, (1996) Detection, assay, and isolation of allene oxide synthase. Methods Enzymol 272: 250-259.
16. Marnett LJ, Tuttle MA, (1980) Comparison of the mutagenicities of malondialdehyde and the side products formed during its chemical synthesis. Cancer Res 40: 276-282.
17. Antone SM, Adderson EE, Mertens NMJ, Cunningham MW, (1997) Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell surface protein laminin. J Immunol 159: 5422-5430.
18. Altschul SF, Madden TL, Schafer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
19. Miller YI, Choi SH, Wiesner P, Fang L, Harkewicz R, et al. (2011) Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 108: 2352-2348.
20. Weismann D, Binder CJ, (2012) The innate immune response to products of phospholipid peroxidation. The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta 1818: 2465-2475.
21. Rindgen D, Nakajima M, Wehrli S, Xu K, Blair IA, (1999) Covalent modifications to 2′-deoxyguanosine by 4-oxo-2-nonenal, a novel product of lipid peroxidation. Chem Res Toxicol 12: 1195-1204.
22. Lee SH, Blair IA, (2000) Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem Res Toxicol 13: 698-702.
23. Furukawa K, Manabe A, Furukawa A, Kuba H, Okajima T, et al. (2006) Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation. Mol Immunol 43: 1751-1760.
24. Krauss N, Wessner H, Welfle K, Welfle H, Scholz C, et al. (2008) The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops. Proteins 73: 552-565.
25. Chavali GB, Papageorgiou AC, Olson KA, Fett JW, Hu G, et al. (2003) The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody. Structure 11: 875-885.
26. Lescar J, Stouracova R, Riottot MM, Chitarra V, Brynda J, et al. (1997) Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody. J Mol Biol 267: 1207-1222.
27. Lipsanen V, Walter B, Emara M, Siminovitch K, Lam J, et al. (1997) Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice. Int Immunol 9: 655-664.
28. Carrillo J, Puertas MC, Planas R, Pastor X, Alba A, et al. (2008) Anti-peripherin B lymphocytes are positively selected during diabetogenesis. Mol Immunol 45: 3152-3162.
29. Katz MS, Foster MH, Madaio MP, (1993) Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences. J Clin Invest 91: 402-408.
30. Sevcik J, Skrabana R, Dvorsky R, Csokova N, Iqbal K, et al. (2007) X-ray structure of the PHF core C-terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer's disease. FEBS Lett 581: 5872-5878.
31. Tanner JJ, Komissarov AA, Deutscher SL, (2001) Crystal structure of an antigen-binding fragment bound to single-stranded DNA. J Mol Biol 314: 807-822.
32. Gibson AL, Herron JN, Ballard DW, Voss EW Jr, He XM, et al. (1985) Crystallographic characterization of the Fab fragment of a monoclonal anti-ss-DNA antibody. Mol Immunol 22: 499-502.
33. Deshmukh US, Bagavant H, Fu SM, (2006) Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev 5: 414-418.
34. Chang MK, Bergmark C, Laurila A, Hörkkö S, Han KH, et al. (1999) Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 96: 6353-6358.
35. Grönwall C, Vas J, Silverman GJ, (2012) Protective roles of natural IgM antibodies. Front Immnol 3: 1-10.
36. Baumgarth N, (2011) The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 11: 34-46.
37. Hartvigsen K, Chou MY, Hansen LF, Shaw PX, Tsimikas S, et al. (2009) The role of innate immunity in atherogenesis. J Lipid Res 50: S388-393.
38. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, et al. (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119: 1335-1349.
39. Silverman GJ, Srikrishnan R, Germar K, Goodyear CS, Andrews KA, et al. (2008) Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients. Clin Exp Immunol 153: 102-116.
40. Doorn JA, Petersen DR, (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem Res Toxicol 15: 1445-1450.
41. Zhu X, Sayre LM, (2007) Long-lived 4-oxo-2-enal-derived apparent lysine michael adducts are actually the isomeric 4-ketoamides. Chem Res Toxicol 20: 165-170.
42. Oe T, Lee SH, Silva Elipe MV, Arison BH, Blair IA, (2003) A novel lipid hydroperoxide-derived modification to arginine. Chem Res Toxicol 16: 1598-1605.
43. Zhang WH, Liu J, Xu G, Yuan Q, Sayre LM, (2003) Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem Res Toxicol 16: 512-523.
44. Yocum AK, Oe T, Yergey AL, Blair A, (2005) Novel lipid hydroperoxide-derived hemoglobin histidine adducts as biomarkers of oxidative stress. J Mass Spectrom 40: 754-764.
45. Shimozu Y, Shibata T, Ojika M, Uchida K, (2009) Identification of advanced reaction products originating from the initial 4-oxo-2-nonenal-cysteine Michael adducts. Chem Res Toxicol 22: 957-964.
46. West JD, Ji C, Duncan ST, Amarnath V, Schneider C, et al. (2004) Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation. Chem Res Toxicol 17: 453-462.
47. Jian W, Arora JS, Oe T, Shuvaev VV, Blair IA, (2005) Induction of endothelial cell apoptosis by lipid hydroperoxide-derived bifunctional electrophiles. Free Radic Biol Med 39: 1162-1176.
48. Lee HP, Zhu X, Zhu X, Skidmore SC, Perry G, et al. (2009) The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells. J Neurochem 108: 1434-1441.
49. Shibata T, Iio K, Kawai Y, Shibata N, Kawaguchi M, et al. (2006) Identification of a lipid peroxidation product as a potential trigger of the p53 pathway. J Biol Chem 281: 1196-1204.
50. Chen Y, Khanna S, Goodyear CS, Park YB, Raz E, et al. (2009) Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183: 1346-1359.
51. Chen Y, Park YB, Patel E, Silverman GJ, (2009) IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 182: 6031-6043.
52. Chang MK, Binder CJ, Miller YI, Subbanagounder G, Silverman GJ, et al. (2004) Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 200: 1359-1370.
53. Witte T, Hartung K, Sachse C, Matthias T, Fricke M, et al. (1998) IgM anti-dsDNA antibodies in SLE: negative association with nephritis. SLE Study Group. Rheumatol Int 18: 85-91.
54. Hahn BH (1998) Antibodies to DNA. N Engl J Med 338; 1359-1368.
55. Boes M, Schmidt T, Linkemann K, Beaudette BC, Marshak-Rothstein A, et al. (2000) Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 97: 1184-1189.
56. Shoenfeld Y, Toubi E, (2005) Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum 52: 2599-2606.